186 related articles for article (PubMed ID: 36797256)
1. B-lymphoid tyrosine kinase-mediated FAM83A phosphorylation elevates pancreatic tumorigenesis through interacting with β-catenin.
Zhou C; Zhu X; Liu N; Dong X; Zhang X; Huang H; Tang Y; Liu S; Hu M; Wang M; Deng X; Li S; Zhang R; Huang Y; Lyu H; Xiao S; Luo S; Ali DW; Michalak M; Chen XZ; Wang Z; Tang J
Signal Transduct Target Ther; 2023 Feb; 8(1):66. PubMed ID: 36797256
[TBL] [Abstract][Full Text] [Related]
2. TSPAN1 promotes autophagy flux and mediates cooperation between WNT-CTNNB1 signaling and autophagy via the
Zhou C; Liang Y; Zhou L; Yan Y; Liu N; Zhang R; Huang Y; Wang M; Tang Y; Ali DW; Wang Y; Michalak M; Chen XZ; Tang J
Autophagy; 2021 Oct; 17(10):3175-3195. PubMed ID: 32972302
[TBL] [Abstract][Full Text] [Related]
3. FAM83A has a pro-tumor function in ovarian cancer by affecting the Akt/Wnt/β-catenin pathway.
Zhao J; Zhao F; Yang T; Tian S; Zhao M; Wang S; Yang X
Environ Toxicol; 2022 Apr; 37(4):695-707. PubMed ID: 34931434
[TBL] [Abstract][Full Text] [Related]
4. Sense and anti-sense: Role of FAM83A and FAM83A-AS1 in Wnt, EGFR, PI3K, EMT pathways and tumor progression.
Zhao C; Li X; Zhang R; Lyu H; Xiao S; Guo D; Ali DW; Michalak M; Chen XZ; Zhou C; Tang J
Biomed Pharmacother; 2024 Apr; 173():116372. PubMed ID: 38432129
[TBL] [Abstract][Full Text] [Related]
5. TRIB3 Interacts With β-Catenin and TCF4 to Increase Stem Cell Features of Colorectal Cancer Stem Cells and Tumorigenesis.
Hua F; Shang S; Yang YW; Zhang HZ; Xu TL; Yu JJ; Zhou DD; Cui B; Li K; Lv XX; Zhang XW; Liu SS; Yu JM; Wang F; Zhang C; Huang B; Hu ZW
Gastroenterology; 2019 Feb; 156(3):708-721.e15. PubMed ID: 30365932
[TBL] [Abstract][Full Text] [Related]
6. FAM83A promotes proliferation and metastasis via Wnt/β-catenin signaling in head neck squamous cell carcinoma.
Ji H; Song H; Wang Z; Jiao P; Xu J; Li X; Du H; Wu H; Zhong Y
J Transl Med; 2021 Oct; 19(1):423. PubMed ID: 34641907
[TBL] [Abstract][Full Text] [Related]
7. FOXO1-regulated lncRNA LINC01197 inhibits pancreatic adenocarcinoma cell proliferation by restraining Wnt/β-catenin signaling.
Ling J; Wang F; Liu C; Dong X; Xue Y; Jia X; Song W; Li Q
J Exp Clin Cancer Res; 2019 Apr; 38(1):179. PubMed ID: 31027497
[TBL] [Abstract][Full Text] [Related]
8. Human telomerase reverse transcriptase (hTERT) is a novel target of the Wnt/β-catenin pathway in human cancer.
Zhang Y; Toh L; Lau P; Wang X
J Biol Chem; 2012 Sep; 287(39):32494-511. PubMed ID: 22854964
[TBL] [Abstract][Full Text] [Related]
9. CREPT/RPRD1B, a recently identified novel protein highly expressed in tumors, enhances the β-catenin·TCF4 transcriptional activity in response to Wnt signaling.
Zhang Y; Liu C; Duan X; Ren F; Li S; Jin Z; Wang Y; Feng Y; Liu Z; Chang Z
J Biol Chem; 2014 Aug; 289(33):22589-22599. PubMed ID: 24982424
[TBL] [Abstract][Full Text] [Related]
10. Tyrosine phosphorylation of LRP6 by Src and Fer inhibits Wnt/β-catenin signalling.
Chen Q; Su Y; Wesslowski J; Hagemann AI; Ramialison M; Wittbrodt J; Scholpp S; Davidson G
EMBO Rep; 2014 Dec; 15(12):1254-67. PubMed ID: 25391905
[TBL] [Abstract][Full Text] [Related]
11. FAM83A is amplified and promotes cancer stem cell-like traits and chemoresistance in pancreatic cancer.
Chen S; Huang J; Liu Z; Liang Q; Zhang N; Jin Y
Oncogenesis; 2017 Mar; 6(3):e300. PubMed ID: 28287611
[TBL] [Abstract][Full Text] [Related]
12. β-Catenin-independent activation of TCF1/LEF1 in human hematopoietic tumor cells through interaction with ATF2 transcription factors.
Grumolato L; Liu G; Haremaki T; Mungamuri SK; Mong P; Akiri G; Lopez-Bergami P; Arita A; Anouar Y; Mlodzik M; Ronai ZA; Brody J; Weinstein DC; Aaronson SA
PLoS Genet; 2013; 9(8):e1003603. PubMed ID: 23966864
[TBL] [Abstract][Full Text] [Related]
13. Wnt-Induced Stabilization of KDM4C Is Required for Wnt/β-Catenin Target Gene Expression and Glioblastoma Tumorigenesis.
Chen Y; Fang R; Yue C; Chang G; Li P; Guo Q; Wang J; Zhou A; Zhang S; Fuller GN; Shi X; Huang S
Cancer Res; 2020 Mar; 80(5):1049-1063. PubMed ID: 31888886
[TBL] [Abstract][Full Text] [Related]
14. IQGAP1 promotes pancreatic cancer progression and epithelial-mesenchymal transition (EMT) through Wnt/β-catenin signaling.
Hu W; Wang Z; Zhang S; Lu X; Wu J; Yu K; Ji A; Lu W; Wang Z; Wu J; Jiang C
Sci Rep; 2019 May; 9(1):7539. PubMed ID: 31101875
[TBL] [Abstract][Full Text] [Related]
15. β-catenin-activated autocrine PDGF/Src signaling is a therapeutic target in pancreatic cancer.
Kuo TL; Cheng KH; Shan YS; Chen LT; Hung WC
Theranostics; 2019; 9(2):324-336. PubMed ID: 30809277
[No Abstract] [Full Text] [Related]
16. DACT2 is a functional tumor suppressor through inhibiting Wnt/β-catenin pathway and associated with poor survival in colon cancer.
Wang S; Dong Y; Zhang Y; Wang X; Xu L; Yang S; Li X; Dong H; Xu L; Su L; Ng SS; Chang Z; Sung JJ; Zhang X; Yu J
Oncogene; 2015 May; 34(20):2575-85. PubMed ID: 25023701
[TBL] [Abstract][Full Text] [Related]
17. SHC4 orchestrates β-catenin pathway-mediated metastasis in triple-negative breast cancer by promoting Src kinase autophosphorylation.
Zhong W; Jian Y; Zhang C; Li Y; Yuan Z; Xiong Z; Huang W; Ouyang Y; Chen X; Song L; Liu P; Wang X
Cancer Lett; 2024 Feb; 582():216516. PubMed ID: 38052369
[TBL] [Abstract][Full Text] [Related]
18. A Small-Molecule Antagonist of the β-Catenin/TCF4 Interaction Blocks the Self-Renewal of Cancer Stem Cells and Suppresses Tumorigenesis.
Fang L; Zhu Q; Neuenschwander M; Specker E; Wulf-Goldenberg A; Weis WI; von Kries JP; Birchmeier W
Cancer Res; 2016 Feb; 76(4):891-901. PubMed ID: 26645562
[TBL] [Abstract][Full Text] [Related]
19. Receptor tyrosine kinases activate canonical WNT/β-catenin signaling via MAP kinase/LRP6 pathway and direct β-catenin phosphorylation.
Krejci P; Aklian A; Kaucka M; Sevcikova E; Prochazkova J; Masek JK; Mikolka P; Pospisilova T; Spoustova T; Weis M; Paznekas WA; Wolf JH; Gutkind JS; Wilcox WR; Kozubik A; Jabs EW; Bryja V; Salazar L; Vesela I; Balek L
PLoS One; 2012; 7(4):e35826. PubMed ID: 22558232
[TBL] [Abstract][Full Text] [Related]
20. ncRNA-mediated upregulation of
Zou W; Wang H; Wu D; Wu Y; Zhou K; Lian Y; Chang G; Feng Y; Liang J; Huang G
Front Endocrinol (Lausanne); 2023; 14():1093042. PubMed ID: 37065746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
